Placebo (vehicle)
Sponsors
Santen Inc., Healthpoint, Renovo, Novartis Pharmaceuticals, Kubota Vision Inc.
Conditions
Atopic DermatitisBurn Degree SecondBurn; Multiple Body Regions, Max. Second DegreeCicatrixDry Eye DiseaseDry Eye SyndromeDry Eye SyndromesFuchs Endothelial Corneal Dystrophy (FECD)
Phase 1
Safety Study of Repeated, Escalating Doses of Intradermal Avotermin (Juvista)
CompletedNCT00978302
Start: 2001-05-31End: 2001-08-31Updated: 2009-09-16
Genomic Changes Associated With the Use of Intradermal Avotermin (Juvista) in Small Wounds in Healthy Male Subjects
CompletedNCT00977951
Start: 2002-09-30End: 2003-09-30Updated: 2009-09-16
A Study Evaluating the Safety and Efficacy of Topical BPR277 for the Treatment of Atopic Dermatitis and Netherton Syndrome
CompletedNCT01428297
Start: 2011-05-31End: 2014-02-28Updated: 2020-12-08
CyclASol® Phase 1 Study
CompletedNCT02113293
Start: 2014-03-31End: 2014-05-31Updated: 2014-05-20
Assessing the Safety and Efficacy of AVX-012 in Subjects With Mild-to-moderate Dry Eye Syndrome
NCT03162094
Start: 2017-04-03End: 2018-12-31Target: 172Updated: 2018-10-01
A Phase 1 Clinical Trial to Explore Systemic Exposure of CTO0101 Eye Drops, Safety and Local Tolerability in Healthy Adults
NCT05262179
Start: 2021-10-05End: 2022-07-05Target: 16Updated: 2022-03-02
Comparing Efficacy and Safety of TJO-083 in Dry Eye Disease Patients
NCT05346783
Start: 2021-10-14End: 2023-06-30Target: 98Updated: 2022-04-26
Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
RecruitingNCT07287033
Start: 2025-12-06End: 2027-04-30Target: 48Updated: 2025-12-30
Phase 2
Dose Finding Study of HP802-247 in Venous Leg Ulcers
CompletedNCT00852995
Start: 2009-02-28End: 2011-07-31Updated: 2016-10-24
Patients With Intermittent Claudication Injected With ALDH Bright Cells
CompletedNCT01774097
Start: 2013-06-30End: 2017-03-31Updated: 2017-04-21
A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease
CompletedNCT04084483
Start: 2019-08-04End: 2020-01-09Updated: 2023-03-15
Safety, Tolerability and Efficacy of Nefopam Cream in Burn Patients
RecruitingNCT04685577
Start: 2022-07-10End: 2026-12-31Target: 60Updated: 2025-01-22
A Phase IIa, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Multicenter Study Assessing the Efficacy and Safety of STN1010904 Ophthalmic Suspension 0.03% and 0.1% Compared with Vehicle in Subjects with Fuchs Endothelial Corneal Dystrophy (FECD) - PHANTOM Study
CompletedCTIS2024-517104-11-00
Start: 2023-06-08End: 2025-05-26Target: 15Updated: 2025-04-01
Phase 3
Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
CompletedNCT01632137
Start: 2012-06-30Updated: 2014-05-07
Clinical Trial to Evaluate the Efficacy and Safety of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease
CompletedNCT05378945
Start: 2022-07-22End: 2023-04-04Updated: 2023-04-25